Durham, North Carolina
United States
69
2025-12-25
62
2026-03-31
These are the the leading inventors for applications assigned to BioCryst Pharmaceuticals, Inc.:
BioCryst Pharmaceuticals, Inc. based in Durham, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR
#2 | 2025-12-25 ✅ Patent 12,545,647 granted on 2026-02-10CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR
#3 | 2025-12-25 ✅ Patent 12,545,646 granted on 2026-02-10CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR
#4 | 2025-12-25 ✅ Patent 12,545,645 granted on 2026-02-10CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR
#5 | 2025-12-11 ✅ Patent 12,590,069 granted on 2026-03-31CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR
#6 | 2025-12-11 ✅ Patent 12,552,750 granted on 2026-02-17CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR
#7 | 2025-06-12 ✅ Patent 12,558,341 granted on 2026-02-24ORAL COMPLEMENT FACTOR D INHIBITORS
#8 | 2024-05-09 ✅ Patent 12,116,346 granted on 2024-10-15Human plasma kallikrein inhibitors
#9 | 2024-05-09 ✅ Patent 12,162,838 granted on 2024-12-10Human plasma kallikrein inhibitors
#10 | 2024-04-04 ✅ Patent 12,344,585 granted on 2025-07-01CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR
#11 | 2023-09-28 ✅ Patent 12,552,827 granted on 2026-02-17SYNTHESIS OF AN ANTIVIRAL AZASUGAR TRIPHOSPHATE
#12 | 2023-08-31 ✅ Patent 12,054,492 granted on 2024-08-06Imidazole-containing inhibitors of ALK2 kinase
#13 | 2023-07-13 ✅ Patent 12,485,109 granted on 2025-12-02BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF
#14 | 2023-03-30 ✅ Patent 11,708,332 granted on 2023-07-25Human plasma kallikrein inhibitors
#15 | 2023-03-30 ✅ Patent 11,866,418 granted on 2024-01-09Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
#16 | 2023-03-30 ✅ Patent 11,708,333 granted on 2023-07-25Human plasma kallikrein inhibitors
#17 | 2023-03-09 ✅ Patent 12,043,610 granted on 2024-07-23Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
#18 | 2023-02-23 ✅ Patent 11,685,721 granted on 2023-06-27Human plasma kallikrein inhibitors
#19 | 2022-11-10 ✅ Patent 11,708,347 granted on 2023-07-25Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
#20 | 2022-10-20 ✅ Patent 11,661,426 granted on 2023-05-30Imidazole-containing inhibitors of ALK2 kinase
#21 | 2022-09-15 ✅ Patent 12,503,443 granted on 2025-12-23PROCESS-SCALE SYNTHESIS OF A PLASMA KALLIKREIN INHIBITOR
#22 | 2022-06-30 ✅ Patent 11,618,733 granted on 2023-04-04Crystalline salts of a plasma kallikrein inhibitor
#23 | 2022-05-26 ✅ Patent 12,589,093 granted on 2026-03-31PLASMA KALLIKREIN INHIBITORS AND METHODS OF USE THEREOF IN OCULAR DISORDERS
#24 | 2022-03-31 ✅ Patent 11,807,605 granted on 2023-11-07Human plasma kallikrein inhibitors
#25 | 2022-02-10 ✅ Patent 12,121,503 granted on 2024-10-22Antiviral treatments
#26 | 2021-08-26 ✅ Patent 11,559,515 granted on 2023-01-24Indole compounds and analogues thereof
#27 | 2021-07-22 ✅ Patent 11,370,774 granted on 2022-06-28Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
#28 | 2021-07-01 ✅ Patent 11,618,731 granted on 2023-04-04Prodrugs of kallikrein inhibitors
#29 | 2021-06-24 ✅ Patent 11,975,003 granted on 2024-05-07Methods and compositions for treatment of Zika virus infection
#30 | 2021-03-18 ✅ Patent 11,230,530 granted on 2022-01-25Human plasma kallikrein inhibitors
#31 | 2021-02-18 ✅ Patent 11,203,574 granted on 2021-12-21Human plasma kallikrein inhibitors
#32 | 2021-02-18 ✅ Patent 11,192,861 granted on 2021-12-07Human plasma kallikrein inhibitors
#33 | 2020-11-19 ✅ Patent 11,066,360 granted on 2021-07-20Human plasma kallikrein inhibitors
#34 | 2020-10-01 ✅ Patent 11,117,867 granted on 2021-09-14Crystalline salts of a plasma kallikrein inhibitor
#35 | 2020-05-07 ✅ Patent 10,662,160 granted on 2020-05-26Crystalline salts of a plasma kallikrein inhibitor
#36 | 2020-03-19 ✅ Patent 10,933,066 granted on 2021-03-02Methods and compositions for treatment of Zika virus infection
#37 | 2019-12-19 ✅ Patent 10,759,759 granted on 2020-09-01Prodrugs of kallikrein inhibitors
#38 | 2019-12-12 ✅ Patent 11,173,159 granted on 2021-11-16Methods and compositions for inhibition of polymerase
#39 | 2019-11-28 ✅ Patent 11,464,755 granted on 2022-10-11Antiviral treatments
#40 | 2019-11-14 ✅ Patent 11,021,458 granted on 2021-06-01Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
#41 | 2019-10-24 ✅ Patent 10,689,346 granted on 2020-06-23Human plasma kallikrein inhibitors
#42 | 2019-08-22 ✅ Patent 11,110,092 granted on 2021-09-07Methods of treating hematologic cancers
#43 | 2019-05-16 ✅ Patent 10,849,883 granted on 2020-12-01Benzopyrazole compounds and analogues thereof
#44 | 2019-03-21 ✅ Patent 10,512,649 granted on 2019-12-24Methods and compositions for treatment of zika virus infection
#45 | 2018-12-20 ✅ Patent 10,562,850 granted on 2020-02-18Human plasma kallikrein inhibitors
#46 | 2018-12-20 ✅ Patent 10,420,769 granted on 2019-09-24Methods and compositions for inhibition of polymerase
#47 | 2018-12-13 ✅ Patent 10,633,345 granted on 2020-04-28Human plasma kallikrein inhibitors
#48 | 2018-09-13 ✅ Patent 10,329,260 granted on 2019-06-25Human plasma kallikrein inhibitors
#49 | 2018-01-18 ✅ Patent 10,391,075 granted on 2019-08-27Antiviral treatments
#50 | 2017-09-21 ✅ Patent 10,905,683 granted on 2021-02-02Compositions and uses of amidine derivatives
#51 | 2017-03-16 ✅ Patent 10,125,102 granted on 2018-11-13Human plasma kallikrein inhibitors
#52 | 2017-02-16 ✅ Patent 10,022,375 granted on 2018-07-17Methods and compositions for inhibition of polymerase
#53 | 2016-04-07 ✅ Patent 9,499,554 granted on 2016-11-22Anti-influenza compositions and methods
#54 | 2015-07-09 ✅ Patent 9,580,428 granted on 2017-02-28Compositions and methods for inhibiting viral polymerase
#55 | 2015-02-19 ✅ Patent 9,492,452 granted on 2016-11-15Methods and compositions for inhibition of polymerase
#56 | 2014-10-16 ✅ Patent 9,770,427 granted on 2017-09-26Antiviral treatments
#57 | 2014-06-26METHODS OF TREATING HEMATOLOGIC CANCERS
#58 | 2013-12-12Methods and Compositions for Inhibition of Polymerase
#59 | 2013-03-21Heterocyclic Compounds as Janus Kinase Inhibitors
#60 | 2012-08-23THERAPEUTIC FUROPYRIMIDINES AND THIENOPYRIMIDINES
#61 | 2012-06-28 ✅ Patent 8,501,753 granted on 2013-08-06Useful pharmaceutical salts of 7-[(3R, 4R)-3-Hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3, 5-dihydro-pyrrolo [3, 2-D] pyrimidin-4-one
#62 | 2012-06-14Pyrrolo [1,2-b] Pyridazine Derivatives as Janus Kinase Inhibitors
#63 | 2012-06-14Heterocyclic Compounds as Janus Kinase Inhibitors
#64 | 2012-06-07ANTIVIRAL THERAPEUTIC AGENTS
#65 | 2012-03-08 ✅ Patent 8,778,997 granted on 2014-07-15Antiviral treatments
#66 | 2011-01-06 ✅ Patent 8,242,085 granted on 2012-08-14Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancer
#67 | 2010-01-21 ✅ Patent 8,440,813 granted on 2013-05-14Antiviral nucleoside analogs
#68 | 2009-09-10 ✅ Patent 7,994,139 granted on 2011-08-09Antiviral therapeutic agents
#69 | 2008-12-04 ✅ Patent 8,133,870 granted on 2012-03-13Therapeutic furopyrimidines and thienopyrimidines
Also check out BioCryst Pharmaceuticals, Inc.'s (Durham, United States) applicant profile with 64 patent applications submitted.
14780 ⎘